Rigel Pharmaceuticals (RIGL) Stock Price, Quote, News & History | Benzinga

Rigel Pharmaceuticals Inc (RIGL) Stock Price, Quote, News & History

RIGLNASDAQ

Trade with Public

Trade with Public

$41.87

-0.15-0.36%

At close: Aug 12, 5:00 PM EST

$41.87

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$42.00

Close

$41.87

Volume / Avg.

335.25K / 383.90K

Day Range

$41.50 - $42.99

52 Wk Range

24.95 - 52.24

Market Cap

$774.68M

P/E Ratio

2.49

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

17.17%

Days to Cover

10.55

Recent Rigel Pharmaceuticals, Inc. News

These Analysts Increase Their Forecasts On Arvinas After Q1 Results

Arvinas Inc (NASDAQ:ARVN) reported Q1 losses of 90 cents/share, missed analyst estimates. Rigel Pharmaceuticals (NASDAQ:RIGL) announced global licensing agreement with Arvinas and Pfizer (NYSE:PFE) for oral PROTAC drug VEPPANU. Arvinas shares rose 1.7% on Wednesday and analysts have raised price targets.

Avi Kapoor

Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer

Rigel Pharmaceuticals stock jumps after signing a VEPPANU licensing deal with Arvinas and Pfizer following recent FDA approval.

Vandana Singh

Nasdaq Surges Over 1%; ISM Services PMI Tops Views

U.S. stocks up on Wednesday with NASDAQ gaining 0.85%. ISM services PMI rose to 56.1. VCI Global Ltd, Latham Group Inc, and Can Fite Biopharma surge.

Avi Kapoor

Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

79.39M

Investing Cash Flow (TTM)

-49.06M

Financing Cash Flow (TTM)

-22.92M

Free Cash Flow (TTM)

9.04M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

7.41M

Analyst Trends and Forecast

4

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$729.92M

PE Ratio (TTM)

2.49

PE Ratio (FWD)

11.85

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.97

PB Ratio (TTM)

1.85

Earnings Yield % (TTM)

40.18%

Earnings Yield % (FWD)

8.44%

EV / EBITDA (TTM)

7.76

Price / EBITDA (TTM)

8.75

Price / Free Cash Flow (TTM)

90.97

Book Value / Share

$22.77

Company Debt

Total Debt

$39.24M

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$62.75M

Total Cash

$60.82M

Debt to Equity

0.09

Issuance of Debt (TTM)

-$22.75M

Repayment of Debt (TTM)

-$62.75M

Key Statistics

Open

$42.00

Close

$41.87

Volume / Avg.

335.25K / 383.90K

Day Range

$41.50 - $42.99

52 Wk Range

24.95 - 52.24

Market Cap

$774.68M

P/E Ratio

2.49

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

17.17%

Days to Cover

10.55

About

Sector

Health Care

Industry

Biotechnology

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsi...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Rigel Pharmaceuticals (RIGL) stock?

A

You can purchase shares of Rigel Pharmaceuticals (NASDAQ:RIGL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Rigel Pharmaceuticals (RIGL) competitors?

A

Other companies in Rigel Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Rigel Pharmaceuticals (RIGL) stock?

A

Rigel Pharmaceuticals has a consensus price target of $44.17.

Q

What is the current price for Rigel Pharmaceuticals (RIGL)?

A

The stock price for Rigel Pharmaceuticals (NASDAQ: RIGL) is $41.87 last updated August 12, 2026 at 4:00 PM EDT.

Q

Does Rigel Pharmaceuticals (RIGL) pay a dividend?

A

There are no upcoming dividends for Rigel Pharmaceuticals.

Q

When is Rigel Pharmaceuticals (NASDAQ:RIGL) reporting earnings?

A

Rigel Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Rigel Pharmaceuticals (RIGL) going to split?

A

There is no upcoming split for Rigel Pharmaceuticals.

Q

What sector and industry does Rigel Pharmaceuticals (RIGL) operate in?

A

Rigel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.